Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Revenue

Tonix Pharmaceuticals Holding had revenue of $6.88M in the quarter ending March 31, 2026, with 183.16% growth. This brings the company's revenue in the last twelve months to $17.56M, up 74.84% year-over-year. In the year 2025, Tonix Pharmaceuticals Holding had annual revenue of $13.11M with 29.85% growth.

• Revenue (ttm): $17.56M
• Revenue Growth: +74.84%
• P/S Ratio: 11.42
• Revenue / Employee: $123,634
• Employees: 142
• Market Cap: 200.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.11M	3.01M	29.85%
Dec 31, 2024	10.09M	2.33M	29.94%
Dec 31, 2023	7.77M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error